306 related articles for article (PubMed ID: 26405155)
41. Osteonecrosis in paediatric patients with acute lymphoblastic leukaemia treated on Co-ALL-07-03 trial: a single centre analysis.
Kuhlen M; Moldovan A; Krull K; Meisel R; Borkhardt A
Klin Padiatr; 2014 May; 226(3):154-60. PubMed ID: 24710762
[TBL] [Abstract][Full Text] [Related]
42. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
[TBL] [Abstract][Full Text] [Related]
43. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
[TBL] [Abstract][Full Text] [Related]
44. Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: possible mechanisms.
Guo CY; Halton JM; Barr RD; Atkinson SA
Oncol Rep; 2004 Jan; 11(1):185-9. PubMed ID: 14654924
[TBL] [Abstract][Full Text] [Related]
45. Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis.
Padhye B; Dalla-Pozza L; Little DG; Munns CF
Pediatr Blood Cancer; 2013 Sep; 60(9):1539-45. PubMed ID: 23625773
[TBL] [Abstract][Full Text] [Related]
46. Bone marrow changes on MRI in children with acute lymphoblastic leukaemia 5 years after treatment.
Ojala AE; Pääkkö E; Lanning FP; Harila-Saari AH; Lanning BM
Clin Radiol; 1998 Feb; 53(2):131-6. PubMed ID: 9502090
[TBL] [Abstract][Full Text] [Related]
47. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition.
Atkinson SA; Halton JM; Bradley C; Wu B; Barr RD
Int J Cancer Suppl; 1998; 11():35-9. PubMed ID: 9876475
[TBL] [Abstract][Full Text] [Related]
48. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy.
Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M
Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694
[TBL] [Abstract][Full Text] [Related]
49. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Hyakuna N; Shimomura Y; Watanabe A; Taga T; Kikuta A; Matsushita T; Kogawa K; Kawakami C; Horikoshi Y; Iwai T; Okamoto Y; Tsurusawa M; Asami K;
J Pediatr Hematol Oncol; 2014 Jan; 36(1):22-9. PubMed ID: 24136019
[TBL] [Abstract][Full Text] [Related]
50. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
[TBL] [Abstract][Full Text] [Related]
51. A
Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
[TBL] [Abstract][Full Text] [Related]
52. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
[TBL] [Abstract][Full Text] [Related]
53. Osteonecrosis in children with acute lymphoblastic leukemia.
Kunstreich M; Kummer S; Laws HJ; Borkhardt A; Kuhlen M
Haematologica; 2016 Nov; 101(11):1295-1305. PubMed ID: 27742768
[TBL] [Abstract][Full Text] [Related]
54. The Progression of Bone Mineral Density Abnormalities After Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
Vitanza NA; Hogan LE; Zhang G; Parker RI
J Pediatr Hematol Oncol; 2015 Jul; 37(5):356-61. PubMed ID: 25222061
[TBL] [Abstract][Full Text] [Related]
55. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia.
Murphy RG; Greenberg ML
Cancer; 1990 Apr; 65(8):1717-21. PubMed ID: 2317754
[TBL] [Abstract][Full Text] [Related]
56. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia.
Swiatkiewicz V; Wysocki M; Odrowaz-Sypniewska G; Koltan A; Manysiak S; Dylewska K
Med Pediatr Oncol; 2003 Dec; 41(6):578-80. PubMed ID: 14595724
[No Abstract] [Full Text] [Related]
57. Osteonecrosis as a complication in pediatric patients with acute lymphoblastic leukemia.
Riccio I; Pota E; Marcarelli M; Affinita MC; Di Pinto D; Indolfi C; Del Regno N; Esposito M
Pediatr Med Chir; 2016 Nov; 38(3):118. PubMed ID: 28009137
[TBL] [Abstract][Full Text] [Related]
58. Bone mineral density in children with acute lymphoblastic leukaemia.
Boot AM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
Eur J Cancer; 1999 Nov; 35(12):1693-7. PubMed ID: 10674015
[TBL] [Abstract][Full Text] [Related]
59. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
[TBL] [Abstract][Full Text] [Related]
60. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
Hartman A; te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Kemper HC; Hop WC; van den Heuvel-Eibrink MM; Pieters R
Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
